Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egbert F Smit

Showing results (211-220 of 367) with videos related to

Pageof 37
Sort By:
Lung Cancer (Amsterdam, Netherlands)|July 28, 2021
Real-world insights into patients with advanced NSCLC and MET alterationsMarisa Bittoni, James Chih-Hsin Yang, Jin-Yuan Shih, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2019
Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)Rafal Dziadziuszko, Egbert F Smit, Urania Dafni, et al.
Pharmaceutical Research|August 17, 2022
Exposure-Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life SettingRené J Boosman, Merel Jebbink, Wouter B Veldhuis, et al.
Radiation Oncology (London, England)|October 8, 2016
Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancerNaomi E Verstegen, Alexander P W M Maat, Frank J Lagerwaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 24, 2015
Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trialAlexander V Louie, Erik van Werkhoven, Hanbo Chen, et al.
ERJ Open Research|June 1, 2017
High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodesRieneke van de Ven, Anna-Larissa N Niemeijer, Anita G M Stam, et al.
The European Respiratory Journal|June 3, 2017
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?Jules L Derks, Robert Jan van Suylen, Erik Thunnissen, et al.
International Journal of Rheumatology|October 12, 2010
Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertensionMaria J Overbeek, Koen T B Mouchaers, Hans M Niessen, et al.
Acta Oncologica (Stockholm, Sweden)|April 30, 2020
Results of neoadjuvant chemo(radio)therapy and resection for stage IIIA non-small cell lung cancer in The NetherlandsPieter J M Joosten, Ronald A M Damhuis, Judi N A van Diessen, et al.
Lung Cancer (Amsterdam, Netherlands)|June 25, 2026
Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primaryTobias Martinot, Lydia H N Schonewille, Dina Ruano, et al.
Pageof 37

Showing results (211-220 of 367) with videos related to

Sort By:
Pageof 37
Lung Cancer (Amsterdam, Netherlands)|July 28, 2021
Real-world insights into patients with advanced NSCLC and MET alterationsMarisa Bittoni, James Chih-Hsin Yang, Jin-Yuan Shih, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2019
Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)Rafal Dziadziuszko, Egbert F Smit, Urania Dafni, et al.
Pharmaceutical Research|August 17, 2022
Exposure-Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life SettingRené J Boosman, Merel Jebbink, Wouter B Veldhuis, et al.
Radiation Oncology (London, England)|October 8, 2016
Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancerNaomi E Verstegen, Alexander P W M Maat, Frank J Lagerwaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 24, 2015
Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trialAlexander V Louie, Erik van Werkhoven, Hanbo Chen, et al.
ERJ Open Research|June 1, 2017
High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodesRieneke van de Ven, Anna-Larissa N Niemeijer, Anita G M Stam, et al.
The European Respiratory Journal|June 3, 2017
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?Jules L Derks, Robert Jan van Suylen, Erik Thunnissen, et al.
International Journal of Rheumatology|October 12, 2010
Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertensionMaria J Overbeek, Koen T B Mouchaers, Hans M Niessen, et al.
Acta Oncologica (Stockholm, Sweden)|April 30, 2020
Results of neoadjuvant chemo(radio)therapy and resection for stage IIIA non-small cell lung cancer in The NetherlandsPieter J M Joosten, Ronald A M Damhuis, Judi N A van Diessen, et al.
Lung Cancer (Amsterdam, Netherlands)|June 25, 2026
Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primaryTobias Martinot, Lydia H N Schonewille, Dina Ruano, et al.
Pageof 37